Privia Health Group CEO Sells Over $496K in Stock

Insider selling activity raises concerns as company faces headwinds

Mar. 11, 2026 at 11:39am

Got story updates? Submit your updates here. ›

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold a significant number of shares in the company, totaling over $496,000 in transactions. The sales, which occurred on March 6th and March 9th, saw Mehrotra reduce his holdings by approximately 63,439 shares. This insider selling activity has raised concerns among investors about the company's future prospects.

Why it matters

Insider selling can often be a signal of management's lack of confidence in a company's future performance. In the case of Privia Health Group, the CEO's substantial stock sales may indicate broader challenges the company is facing, such as increased competition, regulatory changes, or financial headwinds. Investors will be closely watching to see if this trend continues and whether it has any impact on the company's stock price and overall performance.

The details

According to the regulatory filings, CEO Parth Mehrotra sold a total of 21,440 shares on March 6th at an average price of $23.15, and an additional 41,999 shares on March 9th at an average price of $22.86. This resulted in total proceeds of approximately $496,336 from the transactions. Following the sales, Mehrotra's direct ownership in the company decreased to 343,795 shares.

  • On March 6, 2026, CEO Parth Mehrotra sold 21,440 shares at $23.15 per share.
  • On March 9, 2026, CEO Parth Mehrotra sold 41,999 shares at $22.86 per share.

The players

Parth Mehrotra

CEO of Privia Health Group, Inc.

Privia Health Group, Inc.

A physician enablement company that partners with independent physicians, medical groups, and health systems to transform the delivery of patient care.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

The takeaway

The significant insider selling by Privia Health Group's CEO raises concerns about the company's future prospects and may signal broader challenges the business is facing. Investors will be closely monitoring the company's performance and any further developments related to the CEO's stock sales.